Status:
RECRUITING
Artificial Intelligence in Endoscopic Ultrasound
Lead Sponsor:
Orlando Health, Inc.
Conditions:
Pancreatic Cancer
Pancreas Disease
Eligibility:
All Genders
18-100 years
Brief Summary
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound p...
Detailed Description
Endoscopic Ultrasound (EUS) is an equipment where an ultrasound transducer is attached to the tip of the endoscope. When advanced to the stomach the organs outside such as the pancreas and liver can b...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Any patient undergoing endoscopic ultrasound examination
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
January 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT06564571
Start Date
January 19 2024
End Date
December 1 2027
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando Health
Orlando, Florida, United States, 32806